Resilience of patients with sarcopenic obesity and age-related ocular pathology

Cataract in combination with sarcopenic obesity, which is formed mainly against the background of physical inactivity due to vision deficiency, potentially contributes to a decrease in vitality, however, the study of the vitality of patients with sarcopenic obesity and cataract has not been conducted. Purpose: to analysis of the resilience of patients suffering from sarcopenic obesity and cataract. Material and methods. The study involved 135 patients aged 60–74 with cataracts and 126 patients of the same age with cataract and sarcopenic obesity. All patients underwent a comprehensive clinical and instrumental ophthalmological examination. The appropriate criteria presented in the clinical guidelines were used in the diagnosis of cataract. Sarcopenia was determined by the European Working Group on Sarcopenia in older people scale, supplemented by carpal dynamometry, and obesity was determined by body mass index. Resilience was determined on the Connor — Davidson Resilience Scale-25. Results. A separate assessment of the resilience of elderly patients with cataract and sarcopenic obesity and cataract, according to the integral value of the Connor — Davidson Resilience Scale-25, indicates a more significant level of resilience among patients with cataract and sarcopenic obesity with a statistically significant difference between the compared groups. At the same time, despite the significant differences between the groups in most subdomains, in patients with cataract and sarcopenic obesity and cataract, the greatest decrease in vitality was revealed in the subscale of relationship safety and positivity of accepted changes, resistance to adverse influences and trust in personal instincts. Conclusion. The results indicate a more pronounced effect on the decrease in resiliense of sarcopenic obesity and cataracts than cataracts alone, which is confirmed by integral values of vitality having statistically significant differences between the groups.

1. Diago-Galmes A, Guillamon-Escudero C, Tenias-Burillo JM, et al. Sarcopenic obesity in community-dwelling Spanish adults older than 65 years. Nutrients. 2023; 15 (23): 4932. doi: 10.3390/nu15234932

2. Agarkov N.M., Titov A.A., Korneeva S.I., et al. Metabolic syndrome as an urgent health problem (analytical review). Healthcare of the Russian Federation. 2023; 67 (2): 136–41 (In Russ.). doi: 10.47470/0044-197X-2023-67-2-136-141

3. Heber D, Ingles S, Ashley JM, et al. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am J Clin Nutr. 1996; 64 (3): 472–7. doi: 10.1093/ajcn/64.3.472s

4. Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004; 12 (12): 1995–2004. doi: 10.1038/oby.2004.250

5. Kim TN, Yang SJ, Yoo HJ, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009; 33 (8): 885–92. doi: 10.1038/ijo.2009.130

6. Ho KC, Gupta P, Fenwick EK, et al. Association between age-related sensory impairment with sarcopenia and its related components in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2022; 13 (2): 811–23. doi: 10.1002/jcsm.12930

7. Xu T, Wang B, Liu H, et al. Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Lancet Public Health. 2020; 5 (12): е682-е691. doi: 10.1016/s2468-2667(20)30254-1

8. Agarkov N.M., Yablokov M.M., Konyaev D.A., et al. Cognitive and anxiety-depressive disorders in patients suffering from age-related macular degeneration and cataracts. Bulletin of the Russian Military Medical Academy. 2021; 23 (2): 83–90 (In Russ.). doi: 10.17816/brmma71307

9. Burton MJ, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. The Lancet Global Health. 2021; 9 (4):e489-e551. doi: 10.1016/S2214-109X(20)30488-5

10. Osmanov R.E., Aksenov V.V. Prevalence of clinical geriatric syndromes among patients with cataracts. Research Results in Biomedicine. 2023; 9 (2): 268–77 (In Russ.). doi: 10.18413/2658-6533-2023-9-2-2-9

11. Song P, Wang H, Theodoratou E, et al. The national and subnational prevalence of cataract and cataract blindness in China: a systematic review and meta-analysis. J Glob Health. 2018; 8 (1): 010804. doi: 10.7189/jogh.08.010804

12. Fernandez AC, Fehon DC, Treloar H, et al. Resilience in organ transplantation: An application of the Connor–Davidson Resilience Scale (CD–RISC) with liver transplant candidates. Journal of personality assessment. 2015; 97 (5): 487–93. doi: 10.1080/00223891.2015.1029620

13. Windle G. What is resilience? A review and concept analysis. Rev Clin Gerontol. 2011; 21: 152–69. doi: 10.1017/S0959259810000420

14. Clinical recommendations “Senile cataract”. Moscow: Association of Ophthalmologists; 2020 (In Russ.).

15. Wei S, Nguyen TT, Zhang Y, et al. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne). 2023; 14: 1185221. doi: 10.3389/fendo.2023.1185221

16. Gorelik S.G., Ilnitsky A.N., Proschaev K.I., et al. Questionnaires and scales in gerontology and geriatrics. Gerontology. 2021; 9 (1): 1–91 (In Russ.).

17. Wang Y, Zhao Y, Xie S, et al. Resilience mediates the relationship between social support and quality of life in patients with primary glaucoma. Front Psychiatry. 2019; 10: 22. doi: 10.3389/fpsyt.2019.00022

18. Cook C, Foster P. Epidemiology of glaucoma: what's new? Can J Ophthalmol. 2012; 47: 223–6. doi: 10.1016/j.jcjo.2012.02.003

19. Teoli DA, Smith MD, Leys MJ, et al. Visual function affects prosocial behaviors in older adults. Int Ophthalmol. 2016; 36: 45–54. doi: 10.1007/s10792-015-0080-8

20. Popescu ML, Boisjoly H, Schmaltz H, et al. Explaining the relationship between three eye diseases and depressive symptoms in older adults. Invest Ophthalmol Visual Sci. 2012; 53: 2308–13. doi: 10.1167/iovs.11-9330

21. Ghanei GR, Sayehmiri K, Ebadi A, et al. Resilience of patients with chronic physical diseases: a systematic review and meta-analysis. Iran Red Crescent Med J. 2016; 18:e38562. doi: 10.5812/ircmj.38562

22. Smith L, Allen P, Pardhan S, et al. Self-rated eyesight and handgrip strength in older adults. Wien Klin Wochenschr. 2020; 132 (5–6): 132–8. doi: 10.1007/s00508-019-01597-6

23. Harita M, Miwa T, Shiga H, et al. Association of olfactory impairment with indexes of sarcopenia and frailty in community-dwelling older adults. Geriatr Gerontol Int. 2019; 19 (5): 384–91. doi: 10.1111/ggi.13621

24. Cosco TD, Kaushal A, Richards M, et al. Resilience measurement in later life: a systematic review and psychometric analysis. Health Qual Life Outcomes. 2016; 14: 16. doi: 10.1186/s12955-016-0418-6